Assisted Reproductive Technology Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Dec-2019 | List of Tables : 36 | List of Figures : 71 | No. of Pages : 170 | Report Code : FACT4393MR |

Assisted Reproductive Technology Market to Expand 1.4X by 2025, as Public Grants Offset Costs

Advancements in fertilization technology and improved access to fertility clinics, worldwide, continue to boost reproductive success. In the U.S., infertility treatment grants offered by organisations such as the Angels of Hope Foundation, Pay-it-Forward Foundation, and BabyQuest Foundation allow for cost-intensive fertility treatment to be availed by all. Progressive improvements in reproductive outcomes are reflecting on the growing reliance of couples on IVF and IUI technologies, thereby increasing the number of fertility treatment procedures. A cultural shift in the form of same-sex marriage in key economies across the world, is, in turn, found to establish a potent revenue source for the assisted reproductive technology market.

Studying the relevance of all the crucial dynamics, Fact.MR, in its latest study, forecasts that revenue of the assisted reproductive technology market would witness an annual increase of around 6.3% in 2020.

incremental opportunity analysis in assisted reproductive technology market by procedure

For detailed insights on market taxonomy, request a sample copy of the report here.

Fresh Non-donor Fertility Procedures are Deemed Highly Suitable

Adverse effects of demanding lifestyles such as mental stress are taking a toll on the reproductive system of men and women, equally. According to the Centres for Disease Control and Prevention (CDC), nearly 82% of pregnancies resulting from ART cycles use fresh non-donor eggs; the chief reason being, the desire for producing a child using one’s eggs. The trend of using fresh non-donor eggs is especially prominent among women aged less than 35 years.

However, considering delayed family planning and growing influence of chronic diseases such as cancer, medical professionals recommend the medical freezing of eggs for women with a high risk of infertility. Major employers are also taking initiatives to help employees tackle their infertility issues through incentives and perks on the storage of their eggs, which is projected to increase the demand for frozen non-donor procedures. For instance, Facebook, Inc. and Apple Inc. have initiated programs that offer special perks to female employees to store their eggs.

Fertility Clinics Scoring Well in Assisted Reproductive Technology Market

Numerous treatment cycles of infertility treatment using assisted reproductive technology turn the procedure highly expensive. Fertility clinics are magnifying their focus on offering one-stop solutions, ranging from diagnostics to treatment. Investments have also increased towards the development of separate semen and embryology labs to ensure a stable, pathogen-free, and non-toxic environment for gamete handling. Focus of medical professionals of fertility clinics has been on offering quality service to patients by leveraging advanced technology, which, in turn, is boosting the demand for neoteric equipment and devices from fertility clinics. Considering these influences, in 2020 alone, fertility clinics are projected to contribute around US$ 16.8 Bn revenue to the assisted reproductive technology market, which is the highest as compared to hospitals and centres offering similar services.

key regions in assisted reproductive technology market

For detailed regional analysis, request a sample copy of the report here.

Cross-border Reproductive Care Turning into a Phenomena in Assisted Reproductive Technology Market

The study finds that, variations in reimbursement facilities, cost, and patient outcomes in various countries lead to differences in the use of assisted reproductive technology. As per a study published by Springer, 53% of individuals in the Netherlands opt to go abroad to receive quality treatment. Additionally, around 57% to 80% individuals consider legal restriction as one of the chief causes, owing to which, they seek cross-border reproductive care in European countries such as Denmark, Spain, and Switzerland. High-quality fertility treatment services in tandem with the use of advanced technology is creating a favourable growth environment for the European assisted reproductive technology market.

Assisted Reproductive Technology Market – Scope of the Study

The study on the assisted reproductive technology market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that are driving the growth of the market. This exclusive study provides incisive insights regarding the recent developments in the assisted reproductive technology market, by analysing the historical data for the period of 2015-2019, and 2020-2025 as the forecast period.

Estimation of the revenue of the assisted reproductive technology market has been carried out in terms of value (US$ Mn). This research provides information into the key trends that have the potential to influence the growth of the assisted reproductive technology market. Besides this, the study also includes several macroeconomic and microeconomic growth indicators complementing the growth of the assisted reproductive technology market during the forecast period. This insightful report offers the key dynamics, and their impact on the value chain, which are projected to influence the future growth of the assisted reproductive technology market.

The report also provides information into the key challenges and threats that could deter the growth potential of players in the assisted reproductive technology market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global assisted reproductive technology market. With a view of aiding stakeholders in the assisted reproductive technology market, the study comprises a detailed section on the competition analysis.

This exclusive study offers a dashboard view of the assisted reproductive technology market, with detailed information about the market players, based on overall revenue, key developments, and their market presence. Additionally, the key strategies of players in the assisted reproductive technology market have also been included in this comprehensive study.

Assisted Reproductive Technology Market – Assessment of Key Segments

Authors of this comprehensive study have classified the assisted reproductive technology market into key segments for an in-depth study of the market. Categorisation of the assisted reproductive technology market is based on procedure, technology, end user, and region. This detailed study also offers information about the incremental opportunity present in the assistive reproductive technology market during the forecast period. Key segments considered while studying the assisted reproductive technology market include:

Procedure

Technology

End User

Region

Frozen Donor

In-vitro Fertilization

  • Intra-cytoplasmic Sperm Injection (ICSI)
  • Preimplantation Genetic Diagnosis (PGD)

Fertility Clinics

North America

Frozen Non-donor

Surrogacy

Hospitals

Europe

Fresh Donor

Artificial Insemination

  • Intrauterine Insemination (IUI)
  • Intracervical Insemination (ICI)
  • Others

Others

Asia Pacific

Fresh Non-donor

Others

 

Latin America

Embryo Banking

 

 

Middle East and Africa

Authors of the report have taken ample care to track the latest movement of the assisted reproductive technology market, to ensure that only accurate information reaches stakeholders. The study helps these stakeholders in gaining an edge over their competitors. This exclusive guide also tracks the current as well as future trends that are likely to influence the growth of the assisted reproductive technology market during the forecast period.

A list of key companies featured in this study on the assisted reproductive technology market includes Merck KGaA, Esco Micro Pte. Ltd., CooperSurgical, Inc., Planer PLC, Vitrolife AB, Laboratoire CCD, Hamilton Thorne, Inc., Irvine Scientific, Nikon Corporation, and Nidacon International AB. In-depth information about the winning imperatives, threat of new entrants, and substitutes has also been included in this study.

Assisted Reproductive Technology Market – Research Methodology

The primary objective of this exclusive study on the assisted reproductive technology market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2025. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the assisted reproductive technology market, and recalibrate the adoption rate of assisted reproductive technology in key regions across the world.

Request Research Methodology of this report.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Assisted Reproductive Technology Market 

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Key Market Indicators

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity

    4.5. Global Assisted Reproductive Technology Market Analysis and Forecasts, 2020–2025

        4.5.1. Market Revenue Projections (US$ Mn)

    4.6. Assisted Reproductive Technology Market - Global Supply Demand Scenario

    4.7. Porter’s Five Force Analysis

    4.8. Market Outlook

    4.9. Assisted Reproductive Technology: Regional Funding Scenario

    4.10. In Vitro Fertilization Costs, by Region, 2016

    4.11. Assisted Reproductive Technology: Indication

5. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Technology

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value Forecast By Technology, 2020–2025

        5.4.1. In Vitro Fertilization

            5.4.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            5.4.1.2. Preimplantation Genetic Diagnosis (PGD)

        5.4.2. Artificial Insemination

            5.4.2.1. Intrauterine Insemination (IUI)

            5.4.2.2. Intracervical Insemination (ICI)

            5.4.2.3. Others

        5.4.3. Surrogacy

        5.4.4. Others

    5.5. Market Attractiveness By Technology

6. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Procedure 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value Forecast By Procedure, 2020–2025

        6.4.1. Frozen Donor

        6.4.2. Frozen Non Donor

        6.4.3. Fresh Donor

        6.4.4. Fresh Non Donor

        6.4.5. Embryo Banking

    6.5. Market Attractiveness By Procedure 

7. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By End User 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Value Forecast By End User, 2020–2025

        7.4.1. Fertility Clinics 

        7.4.2. Hospitals

        7.4.3. Others

    7.5. Market Attractiveness By End User 

8. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Policies and Regulations

    8.3. Market Value Forecast By Region

        8.3.1. North America 

        8.3.2. Europe 

        8.3.3. Asia Pacific 

        8.3.4. Latin America 

        8.3.5. Middle East and Africa 

    8.4. Market Attractiveness By Country/Region

9. North America Assisted Reproductive Technology Market  Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Policies and Regulations

        9.1.3. Key Trends

    9.2. Market Value Forecast By Technology , 2020–2025

        9.2.1. In Vitro Fertilization

            9.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            9.2.1.2. Preimplantation Genetic Diagnosis (PGD)

        9.2.2. Artificial Insemination

            9.2.2.1. Intrauterine Insemination (IUI)

            9.2.2.2. Intracervical Insemination (ICI)

            9.2.2.3. Others

        9.2.3. Surrogacy

        9.2.4. Others

    9.3. Market Value Forecast By Procedure , 2020–2025

        9.3.1. Frozen Donor

        9.3.2. Frozen Non Donor

        9.3.3. Fresh Donor

        9.3.4. Fresh Non Donor

        9.3.5. Embryo Banking

    9.4. Market Value Forecast By End User , 2020–2025

        9.4.1. Fertility Clinics 

        9.4.2. Hospitals

        9.4.3. Others

    9.5. Market Value Forecast By Country , 2020–2025

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis 

        9.6.1. By Technology

        9.6.2. By Procedure 

        9.6.3. By End User 

        9.6.4. By Country

10. Europe Assisted Reproductive Technology Market  Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Policies and Regulations

        10.1.3. Key Trends

    10.2. Market Value Forecast By Technology , 2020–2025

        10.2.1. In Vitro Fertilization

            10.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            10.2.1.2. Preimplantation Genetic Diagnosis (PGD)

        10.2.2. Artificial Insemination

            10.2.2.1. Intrauterine Insemination (IUI)

            10.2.2.2. Intracervical Insemination (ICI)

            10.2.2.3. Others

        10.2.3. Surrogacy

        10.2.4. Others

    10.3. Market Value Forecast By Procedure , 2020–2025

        10.3.1. Frozen Donor

        10.3.2. Frozen Non Donor

        10.3.3. Fresh Donor

        10.3.4. Fresh Non Donor

        10.3.5. Embryo Banking

    10.4. Market Value Forecast By End User , 2020–2025

        10.4.1. Fertility Clinics 

        10.4.2. Hospitals

        10.4.3. Others

    10.5. Market Value Forecast By Country , 2020–2025

        10.5.1. Germany

        10.5.2. France

        10.5.3. U.K.

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Russia

        10.5.7. Rest of Europe

    10.6. Market Attractiveness Analysis 

        10.6.1. By Technology

        10.6.2. By Procedure 

        10.6.3. By End User 

        10.6.4. By Country

11. Asia Pacific Assisted Reproductive Technology Market  Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Policies and Regulations

        11.1.3. Key Trends

    11.2. Market Value Forecast By Technology, 2020–2025

        11.2.1. In Vitro Fertilization

            11.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            11.2.1.2. Preimplantation Genetic Diagnosis (PGD)

        11.2.2. Artificial Insemination

            11.2.2.1. Intrauterine Insemination (IUI)

            11.2.2.2. Intracervical Insemination (ICI)

            11.2.2.3. Others

        11.2.3. Surrogacy

        11.2.4. Others

    11.3. Market Value Forecast By Procedure, 2020–2025

        11.3.1. Frozen Donor

        11.3.2. Frozen Non Donor

        11.3.3. Fresh Donor

        11.3.4. Fresh Non Donor

        11.3.5. Embryo Banking

    11.4. Market Value Forecast By End User, 2020–2025

        11.4.1. Fertility Clinics 

        11.4.2. Hospitals

        11.4.3. Others

    11.5. Market Value Forecast By Country, 2020–2025

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis 

        11.6.1. By Technology

        11.6.2. By Procedure 

        11.6.3. By End User 

        11.6.4. By Country

12. Latin America Assisted Reproductive Technology Market  Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Policies and Regulations

        12.1.3. Key Trends

    12.2. Market Value Forecast By Technology , 2020–2025

        12.2.1. In Vitro Fertilization

            12.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            12.2.1.2. Preimplantation Genetic Diagnosis (PGD)

        12.2.2. Artificial Insemination

            12.2.2.1. Intrauterine Insemination (IUI)

            12.2.2.2. Intracervical Insemination (ICI)

            12.2.2.3. Others

        12.2.3. Surrogacy

        12.2.4. Others

    12.3. Market Value Forecast By Procedure , 2020–2025

        12.3.1. Frozen Donor

        12.3.2. Frozen Non Donor

        12.3.3. Fresh Donor

        12.3.4. Fresh Non Donor

        12.3.5. Embryo Banking

    12.4. Market Value Forecast By End User , 2020–2025

        12.4.1. Fertility Clinics 

        12.4.2. Hospitals

        12.4.3. Others

    12.5. Market Value Forecast By Country , 2020–2025

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis 

        12.6.1. By Technology

        12.6.2. By Procedure 

        12.6.3. By End User 

        12.6.4. By Country

13. Middle East and Africa Assisted Reproductive Technology Market  Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

        13.1.2. Policies and Regulations

        13.1.3. Key Trends

    13.2. Market Value Forecast By Technology , 2020–2025

        13.2.1. In Vitro Fertilization

            13.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 

            13.2.1.2. Preimplantation Genetic Diagnosis (PGD)

        13.2.2. Artificial Insemination

            13.2.2.1. Intrauterine Insemination (IUI)

            13.2.2.2. Intracervical Insemination (ICI)

            13.2.2.3. Others

        13.2.3. Surrogacy

        13.2.4. Others

    13.3. Market Value Forecast By Procedure , 2020–2025

        13.3.1. Frozen Donor

        13.3.2. Frozen Non Donor

        13.3.3. Fresh Donor

        13.3.4. Fresh Non Donor

        13.3.5. Embryo Banking

    13.4. Market Value Forecast By End User , 2020–2025

        13.4.1. Fertility Clinics 

        13.4.2. Hospitals

        13.4.3. Others

    13.5. Market Value Forecast By Country , 2020–2025

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East and Africa

    13.6. Market Attractiveness Analysis 

        13.6.1. By Technology

        13.6.2. By Procedure 

        13.6.3. By End User 

        13.6.4. By Country

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis By Company (2016)

    14.3. ART Service Providers: Market Snapshot

    14.4. Company Profiles 

        14.4.1. Merck KGaA

            14.4.1.1. Overview

            14.4.1.2. Financials

            14.4.1.3. Recent Developments

            14.4.1.4. Strategy

        14.4.2. CooperSurgical, Inc.

            14.4.2.1. Overview

            14.4.2.2. Financials

            14.4.2.3. Recent Developments

            14.4.2.4. Strategy

        14.4.3. Irvine Scientific.

            14.4.3.1. Overview

            14.4.3.2. Financials

            14.4.3.3. Recent Developments

            14.4.3.4. Strategy

        14.4.4. Vitrolife AB.

            14.4.4.1. Overview

            14.4.4.2. Financials

            14.4.4.3. Recent Developments

            14.4.4.4. Strategy

        14.4.5. Hamilton Thorne, Inc.

            14.4.5.1. Overview

            14.4.5.2. Financials

            14.4.5.3. Recent Developments

            14.4.5.4. Strategy

        14.4.6. Nikon Corporation 

            14.4.6.1. Overview

            14.4.6.2. Financials

            14.4.6.3. Recent Developments

            14.4.6.4. Strategy

        14.4.7. Nidacon International AB 

            14.4.7.1. Overview

            14.4.7.2. Financials

            14.4.7.3. Recent Developments

            14.4.7.4. Strategy

        14.4.8. Laboratoire CCD 

            14.4.8.1. Overview

            14.4.8.2. Financials

            14.4.8.3. Recent Developments

            14.4.8.4. Strategy

        14.4.9. Planer PLC 

            14.4.9.1. Overview

            14.4.9.2. Financials

            14.4.9.3. Recent Developments

            14.4.9.4. Strategy

        14.4.10. Esco Micro Pte. Ltd. (Esco Group)

            14.4.10.1. Overview

            14.4.10.2. Financials

            14.4.10.3. Recent Developments

            14.4.10.4. Strategy

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Assisted Reproductive Technology Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025